MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma

Oncoscience

Volumn 1, Issue 11, 2014, Pages 725-737

  Oyesanya, Regina A ^a,b   Bhatia, Shilpa ^a   Menezes, Mitchell E ^a   Dumur, Catherine I ^a   Singh, Karan P ^c   Bae, Sejong ^c   Troyer, Dean A ^d   Wells, Robert B ^e   Sauter, Edward R ^e   Sidransky, David ^f   Fisher, Paul B ^a   Semmes, Oliver J ^d   Dasgupta, Santanu ^e  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NORFOLK STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF TEXAS AT TYLER   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Differentiation; Head and neck suqamous cell carcinoma; MDA 9 Syntenin; SPRR1B; VEGFR1

Indexed keywords

EID: 84949660806     PISSN: None     EISSN: 23314737     Source Type: Journal    
DOI: 10.18632/oncoscience.99     Document Type: Article

References (35)

1. Rothenberg SM, Ellisen LW. The molecular pathogenesis of head and neck squamous cell carcinoma. Journal of Clinical Investigation. 2012; 122(6):1951-1957.
2. Bose P, Brockton NT, Dort JC. Head and neck cancer: from anatomy to biology. International Journal of Cancer. 2013; 133(9):2013-2023.
3. Sarkar D, Boukerche H, Su ZZ, Fisher PB. Mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Research. 2008; 68(9):3087-3093.
4. Dasgupta S, Menezes ME, Das SK, Emdad L, Janjic A, Bhatia S, Mukhopadhayay ND, Shao C, Sarkar D, Fisher PB. Novel role of MDA-9/Syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clinical Cancer Research. 2013; 19(17):4621-4633.
5. Hao JM, Chen JZ, Sui HM, Si-Ma XQ, Li GQ, Liu C, Li JL, Ding YQ, Li JM. A five-gene signature as a potential predictor of metastasis and survival in colorectal cancer. The Journal of Pathology. 2010; 220(4):475-489.
6. Leemans CR, Braakhuis BJM, Brakenhoff RH. The molecular biology of head and neck cancer. Nature Reviews Cancer. 2011; 11(1):9-22.
7. Zimmermann P, Tomatis D, Rosas M, Grootjans J, Leenaerts I, Degeest G, Reekmans G, Coomans C, David G. Characterization of syntenin, a syndecan-binding PDZ protein, as a component of cell adhesion sites and microfilaments. Molecular Biology of the Cell. 2001; 12(2):339-350.
8. Lin JJ, Jiang H, Fisher PB. Melanoma differentiation associated gene-9, mda-9, is a human gamma interferon responsive gene. Gene. 1998; 207(2):105-10.
9. Reddy SP, Chuu YJ, Lao PN, Donn J, Ann DK, Wu R. Expression of human squamous cell differentiation marker, SPR1, in tracheobronchial epithelium depends on JUN and TRE motifs. The Journal of Biological Chemistry. 1995; 270(44):26451-26459.
10. Patterson T, Vuong H, Liaw YS, Wu R, Kalvakolanu DV, Reddy SP. Mechanism of repression of squamous differentiation marker, SPRR1B, in malignant bronchial epithelial cells: role of critical TRE-sites and its transacting factors. Oncogene. 2001; 20(5):634-644.
11. Carregaro F, Stefanini AC, Henrique T, Tajara EH. Study of small proline-rich proteins (SPRRs) in health and disease: a review of the literature. Archives of Dermatology Research. 2013; 305(10):857-866.
12. Hippo Y, Yashiro M, Ishii M, Taniguchi H, Hirakawa K, Kodama T, Aburatani H. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes. Cancer Research. 2001; 61(3):889-895.
13. Bhave SL, Teknos TN, Pan Q. Molecular parameters of head and neck cancer metastasis. Critical Reviews in Eukaryotic Gene Expression. 2011; 21(2):143-153.
14. Park BJ, Chiosea SI, Grandis JR. Molecular changes in the multistage pathogenesis of head and neck cancer. Cancer Biomarkers. 2010; 9(1-6):325-339.
15. Bockmühl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, Peterson I. Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Research. 1997; 57(23):5213-5216.
16. Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, et al. Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discovery. 2013; 3(7):770-781.
17. Tesfaigzi Y, Wright PS, Belinsky SA. SPRR1B overexpression enhances entry of cells into the G0 phase of the cell cycle. American Journal of Physiology. Lung Cellular and Molecular Physiology. 2003; 285(4):L889-898.
18. Qian XL, Li YQ, Yu B, Gu F, Liu FF, Li WD, Zhang XM, Fu L. Syndecan binding protein (SDCBP) is overexpressed in estrogen receptor negative breast cancers, and is a potential promoter for tumor proliferation. PLoS One. 2013; 8(3):e60046.
19. Miyoshi K, Hennighausen L. Beta-catenin: a transforming actor on many stages. Breast Cancer Research. 2003; 5(2):63-68.
20. Neuchrist C, Erovic BM, Handisurya A, Fischer MB, Steiner GE, Hollemann D, Gedlicka C, Saaristo A, Burian M. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 expression in squamous cell carcinomas of the head and neck. Head & Neck. 2003; 25(6):464-474.
21. Silva SD, Alaoui-Jamali MA, Hier M, Soares FA, Graner E, Kowalski LP. Cooverexpression of ERBB1 and ERBB4 receptors predicts poor clinical outcome in pN+ oral squamous cell carcinoma with extranodal spread. Clinical & Experimental Metastasis. 2014; 31(3):307-316.
22. Gyanchandani R, Ortega Alves MV, Myers JN, Kim S. A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma. Molecular Cancer Research. 2013; 11(12):1585-1596.
23. Phay JE, Shah MH. Targeting RET receptor tyrosine kinase activation in cancer. Clinical Cancer Research. 2010; 16(24):5936-5941.
24. Deng L, Chen N, Li Y, Zheng H, Lei Q. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer. Biochimica et Biophysica Acta. 2010; 1806(1):42-49.
25. Sargiannidou I, Zhou J, Tuszynski GP. The role of thrombospondin-1 in tumor progression. Experimental Biology and Medicine (Maywood). 2001; 226(8):726-733.
26. Wang TN, Qian X, Granick MS, Solomon MP, Rothman VL, Berger DH, Tuszynski GP. Thrombospondin-1 (TSP-1) promotes the invasive properties of human breast cancer. The Journal of Surgical Research. 1996; 63(1):39-43.
27. Natsuizaka M, Kinugasa H, Kagawa S, Whelan KA, Naganuma S, Subramanian H, Chang S, Nakagawa KJ, Rustgi NL, Kita Y, Natsugoe S, Basu D, Gimotty PA, et al. IGFBP3 promotes esophageal cancer growth by suppressing oxidative stress in hypoxic tumor microenvironment. American Journal of Cancer Research. 2014; 4(1):29-41.
28. Martin JL, de Silva HC, Lin MZ, Scott CD, Baxter RC. Inhibition of insulin-like growth factor-binding protein-3 signaling through sphingosine kinase-1 sensitizes triplenegative breast cancer cells to EGF receptor blockade. Molecular Cancer Therapeutics. 2014; 13(2):316-328.
29. St John MA, Li Y, Zhou X, Denny P, Ho CM, Montemagno C, Shi W, Qi F, Wu B, Sinha U, Jordan R, Wolinsky L, Park NH, Liu H, et al. Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Archives of Otolaryngology-Head & Neck Surgery. 2004; 130(8):929-935.
30. Bancroft CC, Chen Z, Dong G, Sunwoo JB, Yeh N, Park C, Van Waves C. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKKNF-kappaB signal pathways. Clinical Cancer Research. 2001; 7(2):435-442.
31. He Y, Karpanen T, Alitalo K. Role of lymphangiogenic factors in tumor metastasis. Biochimica et Biophysica Acta. 2004; 1645(1):.
32. Karatzanis AD, Koudounarakis E, Papadakis I, Velegrakis G. Molecular pathways of lymphangiogenesis and lymph node metastasis in head and neck cancer. European Archives of Oto-rhino-laryngology. 2012; 269(3):731-737.
33. Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Research. 2008; 68(3):700-706.
34. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Research. 2003; 31(4):e15.
35. Storey JD. A direct approach to false discovery rates. Journal of the Royal Statistical Society. 2002; 64(3):479-498.